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Filopodia assemble unique integrin-adhesion complexes as they
sense and attach to the surrounding extracellular matrix. In-
tegrin activation is essential for filopodia stability; however,
the regulation of integrin activity within filopodia is poorly de-
fined. Using structured illumination and scanning electron mi-
croscopy, we observed that active integrin is spatially confined
to filopodia tips and inactive integrin localises throughout the
filopodia shaft. RNAi depletion of integrin regulators identified
FERM domain containing talin and MYO10 as critical regu-
lators of filopodia function. Importantly, deletion of MYO10-
FERM ablates the active pool of integrin from filopodia, indicat-
ing that MYO10-FERM domain is required for integrin activa-
tion but not for integrin transport to filopodia tips. Yet, remark-
ably, the MYO10-FERM domain binds both α and β integrin
tails restricting integrin activation. Swapping MYO10-FERM
with talin-FERM leads to an over-activation of integrin recep-
tors in filopodia. Our observations demonstrate a complex reg-
ulation of integrin activity, at filopodia tips, via MYO10-FERM
domain and challenge the concept of MYO10-dependent inte-
grin transport in filopodia.
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Introduction
Filopodia are actin-rich “antenna-like” protrusions that
are responsible for constantly probing the cellular environ-
ment composed of neighbouring cells and the extracellular
matrix (ECM). As such, filopodia contain cell-surface recep-
tors such as integrins, cadherins and growth factor receptors
that can interact with, and interpret, a wide variety of extra-
cellular cues (Jacquemet et al., 2015). Filopodia are espe-
cially abundant in cells as they migrate in 3D and in vivo
where they contribute to efficient directional migration by
probing and remodelling the surrounding ECM (Jacquemet
et al., 2013, 2017; Paul et al., 2015).
Filopodia have a unique cytoskeleton composed of
tightly packed parallel actin filaments with barbed ends ori-
ented towards the filopodium tip (Mattila and Lappalainen,
2008). This organisation allows molecular motors, such as
unconventional myosin-X (MYO10), to move towards and
accumulate at filopodia tips. By doing so, these molecu-
lar motors are thought to transport various proteins, includ-
ing integrins, along actin filaments to the tips of filopodia
(Jacquemet et al., 2015; Arjonen et al., 2014; Berg and Ch-
eney, 2002; Hirano et al., 2011; Zhang et al., 2004). In par-
ticular, MYO10 is known to bind directly to the NPxY mo-
tif of the β-integrin cytoplasmic tail via its FERM (protein
4.1R, ezrin, radixin, moesin) domain (Zhang et al., 2004).
At filopodia tips, integrins assemble a specific adhesion com-
plex that tethers filopodia to the ECM (Alieva et al., 2019;
Jacquemet et al., 2019; Gallop, 2019). The subsequent matu-
ration of these filopodia tip adhesions into nascent and focal
adhesions can then promote directional cell migration (Hu et
al., 2014; Jacquemet et al., 2016, 2019).
Integrin functions are tightly regulated by a conforma-
tional switch that modulates ECM binding, often referred to
as activation. Integrin extracellular domain conformations
can range from a bent to an extended open conformation,
where the integrin’s ligand affinity increases with stepwise
opening (Conway and Jacquemet, 2019; Sun et al., 2019;
Askari et al., 2009). For β1 integrin, this unfolding can
be viewed using activation-specific antibodies (Byron et al.,
2009). Mechanistically, integrin activity can be finely tuned,
from within the cell, by multiple proteins that bind to the in-
tegrin cytoplasmic tails (Conway and Jacquemet, 2019; Sun
et al., 2019; Askari et al., 2009). For instance, talin, a key
integrin activator, can bind to the NPxY motif of the β inte-
grin cytoplasmic tail leading to the physical separation of the
integrin α and β cytoplasmic tails and integrin activation (Sun
et al., 2019). While it is clear that integrins and integrin sig-
nalling are key regulators of filopodia function (Lagarrigue et
al., 2015; Jacquemet et al., 2016, 2019; Gallop, 2019), how
integrin activity is regulated within filopodia remains unstud-
ied.
Using super-resolution microscopy, we observed that
integrin activation is spatially controlled within filopodia,
where active integrin accumulates at filopodia tips, and in-
active integrin localises throughout the filopodia shaft. We
demonstrate that integrin activation at filopodia tips occurs
independently of the rest of the cell and is instead locally
regulated by talin and MYO10. We report that contrary to
previous assumptions, the MYO10-FERM domain is not re-
quired to transport integrin to filopodia but is instead required
to localise active integrin to filopodia tips. Counterintuitively,
we discovered that MYO10-FERM itself is capable of inac-
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tivating integrins by binding to both the α and β integrin sub-
unit cytoplasmic tails and presumably cross-linking the het-
erodimer. Yet, remarkably, swapping MYO10-FERM with
talin-FERM rescued filopodia function and integrin activa-
tion at filopodia tips, suggesting an unanticipated level of in-
terchangeability between FERM domains in spatially regu-
lating integrin activation in filopodia.
Main text
Active integrins accumulate at filopodia tips. We and
others have previously described the formation of integrin-
mediated adhesions at filopodia tips and that these structures
are required for ECM sensing (Shibue et al., 2012; Jacquemet
et al., 2019; Lagarrigue et al., 2015; Alieva et al., 2019; Gal-
lop, 2019). To gain insight into how integrin activity is reg-
ulated in filopodia, we first assessed the spatial distribution
of active and inactive β1 integrin in U2-OS cells transiently
expressing fluorescently-tagged MYO10 using structured il-
lumination microscopy (SIM) (Fig. 1A and 1B) and scanning
electron microscopy (SEM) (Fig. 1C). The average distribu-
tion of the β1 integrin species along filopodia was mapped
from both the SIM and the SEM images (Fig. 1B and 1C) re-
vealing that active β1 integrins mainly accumulate at filopo-
dia tips (active integrin detected in 68% of filopodia tips). In
contrast, inactive β1 integrins are distributed along the entire
length of the filopodium. Importantly, this pattern of inte-
grin localisation was recapitulated in endogenous filopodia,
forming in actively spreading cells, and thus is not a specific
feature of cells over-expressing MYO10 (Fig. 1D and 1E).
Previous work reported that forces generated by the ac-
tomyosin machinery are required for integrin-mediated adhe-
sion at filopodia tips (Alieva et al., 2019). In addition, we ob-
served that filopodia often align to the force generated by fo-
cal adhesions (Stubb et al., 2020). Therefore, we investigated
whether cellular forces generated by the cell body and trans-
mitted at focal adhesions were responsible for integrin activa-
tion at filopodia tips. U2-OS cells expressing fluorescently-
tagged MYO10 and adhering to fibronectin were treated with
DMSO, a myosin II inhibitor (10 µM blebbistatin) or an es-
tablished focal adhesion inhibitor (CDK1 inhibitor, 10 µM
RO-3306 (Robertson et al., 2015; Jones et al., 2018)). As
expected, inhibition of myosin II or CDK1 led to rapid dis-
assembly of focal adhesions (Fig. 1F and S1A). Blebbistatin
treatment promoted longer and more numerous filopodia, in
line with our earlier report (Stubb et al., 2020), while treat-
ment with the CDK1 inhibitor increased filopodia numbers
but not filopodia length (Fig. S1B and S1C). However, no
decrease in filopodial integrin activation could be observed
when myosin II or CDK1 were inhibited (Fig. 1F and 1G). In
contrast, CDK1 inhibition led to an increase in the percentage
of filopodia with active integrin at their tips (Fig. 1H). Alto-
gether these data indicate that integrin activation at filopodia
tips is regulated independently of cellular forces and focal
adhesions. However, cellular forces are likely required to in-
duce filopodia adhesion maturation into focal adhesions and
for efficient ECM sensing (Alieva et al., 2019; Jacquemet et
al., 2019).
Inside-out integrin activation in filopodia . The obvious en-
richment of active β1 integrin at filopodia tips (Fig. 1) indi-
cates that β1 integrin activation is likely to be spatially reg-
ulated by one or multiple components of the filopodium tip
complex. We and others have previously reported that sev-
eral proteins implicated in the regulation of integrin activity,
including the integrin activators talins and kindlins as well as
the integrin inactivator ICAP-1 (ITGB1BP1), accumulate at
filopodia tips where their function remains mostly unknown
(Lagarrigue et al., 2015; Jacquemet et al., 2019). In addi-
tion, we previously reported that modulation of integrin ac-
tivity often correlates with increased filopodia numbers and
stability (Jacquemet et al., 2016). Therefore, to test the con-
tribution of 10 known integrin activity regulators to filopodia
formation, a microscopy-based siRNA screen was performed
in U2-OS cells stably expressing MYO10-GFP (Fig. S1D)
(Jacquemet et al., 2016). The silencing efficiency of each
siRNA was validated by qPCR (Fig. S1E) or western blot
(Fig. S1F), and silencing of MYO10 was included as a posi-
tive control. Surprisingly, of the ten integrin regulators, only
talin (combined TLN1 and TLN2) silencing significantly in-
fluenced filopodia numbers. As kindlin-2 (FERMT2) is a ma-
jor regulator of integrin activity (Theodosiou et al., 2016) and
FERMT2 localises to filopodia tips (Jacquemet et al., 2019),
we were surprised by the inability of FERMT2 silencing to
impact filopodia and therefore we decided to explore this fur-
ther. Dual silencing of FERMT1 and FERMT2 did not affect
filopodia number or dynamics suggesting that kindlins are
not directly required to support filopodia formation or adhe-
sion under the conditions tested (Fig. S1G-I). Altogether, our
data indicate that, in line with our previous work (Jacquemet
et al., 2016), talin and MYO10 are key regulators of filopodia
functions. As Rap1 also plays a key role in filopodia func-
tions (Lagarrigue et al., 2015; Jacquemet et al., 2016), future
work will aim to unravel if talin is directly activated by Rap1
in filopodia (Gingras et al., 2019; Zhu et al., 2017) or if Riam
is also required (Lagarrigue et al., 2015).
The FERM domain of MYO10 is required for integrin activa-
tion at filopodia tips. MYO10 directly binds to integrins via
its FERM domain (Hirano et al., 2011; Zhang et al., 2004).
In this context, MYO10 is thought to actively transport in-
tegrins as well as other cargo to filopodia tips. Therefore,
we next assessed the contribution of MYO10-FERM domain
to the localisation of the various integrin species in filopodia
by creating a FERM domain deletion construct (MYO10ΔF)
(Fig. 2A). Importantly, we carefully designed this construct
by taking into consideration the previously reported MYO10-
FERM domain structures (PDB ids: 3pzd and 3au5) (Wei et
al., 2011; Hirano et al., 2011). MYO10ΔF was expressed in
U2-OS cells, which express very low levels of endogenous
MYO10 (Young et al., 2018; Jacquemet et al., 2016) (Fig.
2B). Deletion of the MYO10-FERM domain led to a small
but significant reduction in filopodia number accompanied
with a reduction in filopodia length, in line with previous re-
ports (Zhang et al., 2004; Watanabe et al., 2010) (Fig. 2C and
2D). Strikingly, the majority of MYO10ΔF-filopodia (80%)
were devoid of active β1 integrins at their tips (Fig. 2E and
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Fig. 1. Active Integrins accumulate at filopodia tips independently of cellular forces A) U2-OS cells expressing mScarlet-MYO10 or EGFP-MYO10 were plated on
fibronectin for 2 h, stained for active (clone 12G10 and HUTS21) or inactive (clone 4B4 and mAb13) β1 integrin and F-actin, and imaged using structured illumination
microscopy (SIM). Representative maximum intensity projections (MIPs) are displayed. The yellow squares highlight regions of interest (ROIs), which are magnified; yellow
arrows highlight filopodia tips; scale bars: (main) 20 µm; (inset) 2 µm. B) Heatmap highlighting the sub-filopodial localisation of the proteins stained in A based on their
intensity profiles (See methods for details, MYO10, n = 623 filopodia; F-actin, n = 623 filopodia; HUTS21, n = 538 filopodia; 12G10, n = 329 filopodia; 4B4, n = 413 filopodia;
mAb13, n = 369 filopodia; thee biological repeats). The segments corresponding to the filopodia tip and shaft are indicated.
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Fig. 1. (Continued from previous page.) C) U2-OS cells were plated on fibronectin for 2h, stained for active (clone 12G10) or inactive (clone 4B4) β1 integrin and imaged
using a scanning electron microscope (SEM). Representative images are displayed. The upper row was acquired using a secondary electron detector (SED) and the lower
row using a backscattered electron detector (vCD). The distance of the two β1 integrin pools from the filopodia tip (defined by the gold particles, highlighted by yellow arrows)
was measured and the results displayed as a density plot (4B4 staining n = 175 gold particles; 12G10 staining n = 178 gold particles). A bootstrap version of the univariate
Kolmogorov-Smirnov test was used for statistical testing. p-value < 0.001. D-E) U2-OS cells were plated on fibronectin for 20 min, stained for active (D, clone 12G10) or
inactive (E, clone 4B4) β1 integrin and F-actin, and imaged using SIM. Representative MIPs are displayed. The yellow squares highlight ROIs, which are magnified; yellow
arrows highlight filopodia tips; scale bars: (main) 20 µm; (inset) 2 µm. F-H) U2-OS cells expressing EGFP-MYO10 were plated on fibronectin for 1 h and treated for 1 h with
10 µM blebbistatin (myosin II inhibitor), 10 µM RO-3306 (CDK1 inhibitor) or DMSO. Cells were stained for active β1 integrin (clone 12G10) and F-actin, and imaged using
SIM. F) Representative MIPs are displayed. The yellow squares highlight ROIs, which are magnified; yellow arrows highlight filopodia tips; scale bars: (main) 20 µm; (inset)
2 µm. G) Heatmap displaying the sub-filopodial localization of active β1 integrin in cells treated with DMSO, blebbistatin or RO-3306 (DMSO, n = 734 filopodia; RO-3306, n =
824 filopodia; blebbistatin, n = 483 filopodia; three biological repeats). H) Bar chart highlighting the percentage of filopodia with detectable levels of active β1 integrin in cells
treated with DMSO, blebbistatin or RO-3306 (DMSO, n = 734 filopodia; RO-3306, n = 824 filopodia; blebbistatin, n = 483 filopodia; three biological repeats).
2F). However, this lack of active β1 integrin was not due to
an absence of β1 integrin in filopodia, as the uniform inactive
β1 integrin distribution along the filopodia was unaffected by
the MYO10-FERM domain deletion (Fig. 2E and 2F). In line
with these results, MYO10ΔF-induced filopodia were unsta-
ble and unable to attach to the underlying ECM (Fig. 2G and
Video 1). Taken together, these findings demonstrate that
MYO10 supports integrin activation at filopodia tips via its
FERM domain. However, MYO10-FERM domain is not re-
quired to localise and/or accumulate β1 integrin to filopodia
(Fig. 2). These findings challenge the model of MYO10-
FERM domain acting as a cargo-transporter of integrin to
filopodia tips.
MYO10-FERM deletion does not influence the localisation of
key filopodia tip components. As MYO10-FERM domain
is thought to be the major cargo binding site in MYO10 (Wei
et al., 2011), we hypothesized that the lack of integrin activa-
tion at the tip of MYO10ΔF filopodia would be due to the ab-
sence of a key integrin activity modulator. We co-expressed
six established filopodia tip components (Jacquemet et al.,
2019), TLN1, FERMT2, CRK, DIAPH3, BCAR1 and VASP,
with either MYO10WT or MYO10ΔF. SIM microscopy re-
vealed that the localization of these proteins was unaffected
by MYO10-FERM domain deletion (Fig. S2). Interest-
ingly, VASP has been previously described as a MYO10-
FERM cargo but its localisation at filopodia tips was clearly
un-affected by MYO10-FERM deletion (Young et al., 2018;
Tokuo and Ikebe, 2004; Lin et al., 2013). Altogether, our
results demonstrate that the recruitment of key filopodia tip
proteins is independent of MYO10-FERM domain and sug-
gest that MYO10-FERM may regulate integrin activity via
another mechanism than cargo transport.
MYO10-FERM domain alone inactivates integrin. The talin-
FERM domain is necessary and sufficient to activate integrins
(Anthis et al., 2009; Lilja et al., 2017), and the MYO10-
FERM domain is required to activate integrin at filopodia tips
(Fig 2). Superimposition of the talin and MYO10-FERM do-
main revealed that both FERM domains adopt a similar fold,
within the talin sub-domains that bind to the β integrin tail
(talin F2 and F3). While the site where MYO10-FERM binds
to the β integrin tail remains unknown, this structural align-
ment suggests that talin-FERM and MYO10-FERM may op-
erate in a similar fashion (Fig. 3A). To assess whether
MYO10-FERM modulates integrin activity, we employed a
flow cytometric assay to measure active cell-surface integrins
relative to total cell-surface integrins (Lilja et al., 2017) (Fig.
3B-D). As expected overexpression of the talin-FERM do-
main significantly increased integrin activity (Fig. 3B). In
contrast, overexpression of the MYO10-FERM domain led
to a small but highly reproducible decrease in integrin activ-
ity in CHO and U2-OS cells (Fig. 3B-C). A similar decrease
in integrin activity could also be measured when full-length
MYO10 was overexpressed in U2-OS cells (Fig. 3C). Con-
versely, silencing of MYO10 in MDA-MB-231 cells, where
mutant p53 drives high endogenous MYO10 levels (Arjonen
et al., 2014), increased integrin activity. Importantly, reintro-
duction of full-length MYO10 reversed the increased integrin
activity in MYO10-silenced cells (Fig. 3D and S3A). Integrin
activity levels have an impact on cellular functions, including
cell adhesion and spreading (Lilja et al., 2017). Consistent
with decreased integrin activation, MYO10-FERM expres-
sion attenuated cell adhesion/spreading on fibronectin over
time as measured with the xCELLigence apparatus or by
measuring cell spreading area (Fig. 3E-G) (Hamidi et al.,
2017). Altogether our data indicate, unexpectedly, that even
though MYO10-FERM domain is necessary for spatially re-
stricted integrin activation at filopodia tips, MYO10-FERM
domain is capable of inactivating integrins.
MYO10-FERM domain binds to both α and β integrin tails .
Given the unexpected ability of MYO10-FERM domain to
inactivate integrins (Fig. 3), we next investigated MYO10-
FERM and talin-FERM interaction with integrin cytoplas-
mic tails. Recombinant His-tagged MYO10 and talin-FERM
domains were expressed in bacteria, purified (Fig S3B), and
their binding affinity to integrin α and β tails was measured
using microscale thermophoresis (Fig. 4A and Fig. 4B; see
methods for details) (Jerabek-Willemsen et al., 2014). As ex-
pected, the FERM domain of talin bound to the β1 and β5
integrin tails (measured affinities of 4.7 µM and 12 µM, re-
spectively) but not to the α integrin tails (Goult et al., 2009).
In contrast, the MYO10-FERM interacted with all the α and
β integrin-tails tested with affinities ranging from 4 to 25 µM
(Fig. 4A and Fig. 4B). This result was surprising as we had
not expected MYO10-FERM to bind to α integrin-tails. A
shared feature in α-integrin tails (including α5 and α2 inte-
grin) is the highly conserved membrane-proximal GFFKR
motif. Importantly, mutation of this GFFKR motif in the α2-
integrin tail (FF/AA mutation, named ITGA2GAAKR) abol-
ished the binding of recombinant MYO10-FERM in vitro
(Fig. 4C), indicating that MYO10 interaction with α-subunit
cytoplasmic tails requires an intact GFFKR-motif. Impor-
tantly, endogenous MYO10 interacted with both β1 and α2
integrin peptides (Fig. 4D), whereas the clathrin adaptor
AP2µ, a known α2 integrin tail binder (De Franceschi et al.,
2016), only interacted with the α2 integrin tail (Fig. 4D). Fur-
thermore, the ITGA2GAAKR peptide was defective in interact-
ing with full-length MYO10 (Fig. 4E), but AP2µ recruitment
was unaffected (AP2µ binds to a separate motif in the α2-
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Fig. 2. MYO10-FERM domain is required for integrin activation in filopodia. A) Cartoon illustrating the EGFP-MYO10WT and EGFP-MYO10∆F constructs. B-C) U2-
OS cells transiently expressing EGFP-MYO10WT or EGFP-MYO10∆F were plated on fibronectin for 2 h, fixed and imaged using a spinning-disk confocal microscope. B)
Representative MIPs are displayed. Scale bar: 25 µm. C) The number of MYO10-positive filopodia per cell was then quantified (n > 85 cells, three biological repeats; ***
p-value <0.001). D) Quantification of filopodia length in U2-OS cells transiently expressing EGFP-MYO10WT or EGFP-MYO10∆F from SIM images (EGFP-MYO10WT, n =
512 filopodia; EGFP-MYO10∆F, n = 283 filopodia; three biological repeats; *** p value = <0.001). E) U2-OS cells expressing EGFP-MYO10∆F were plated on fibronectin
for 2 h, stained for active (clone 12G10) or inactive (clone 4B4) β1 integrin and F-actin, and imaged using SIM. Representative MIPs are displayed. The yellow squares
highlight ROIs, which are magnified; yellow arrows highlight filopodia tips; scale bars: (main) 20 µm; (inset) 2 µm. F) Heatmap highlighting the sub-filopodial localisation of
the proteins stained in (E) generated from their intensity profiles measured within filopodia (EGFP-MYO10WT, n = 512 filopodia; EGFP-MYO10∆F, n = 283 filopodia; three
biological repeats). G) U2-OS cells expressing EGP-MYO10WT or EGFP-MYO10∆F were plated on fibronectin and imaged live using an Airyscan confocal microscope (1
picture every 5 s over 20 min; scale bar = 25 µm; Video 1). For each condition, MYO10-positive particles were automatically tracked, and MYO10 spot lifetime (calculated as
a percentage of the total number of filopodia generated per cell) was plotted and displayed as boxplots (see Methods for details; three biological repeats; EGP-MYO10WT, n=
33 cells; EGFP-MYO10∆F, n= 38 cells, *** p-value < 0.006). For all panels, p-values were determined using a randomization test.
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Fig. 3. MYO10-FERM domain inhibits integrin activity. A) Visualisation of the structure of MYO10-FERM (PDB: 3PZD; (Wei et al., 2011)) and TLN1-FERM (PDB: 3IVF,
(Elliott et al., 2010)) domains using PyMOL. The black arrows indicate the protein orientation from N to C terminal. The two FERM domains were superimposed to highlight
their structural homology and differences. The integrin binding region on the talin-FERM domain is highlighted and magnified.
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Fig. 3. (Continued from previous page.) B) CHO cells expressing EGFP or the EGFP-tagged FERM domains of TLN1 (EGFP-TLN1FERM) or MYO10 (EGFP-MYO10FERM)
were either incubated with an Alexa647- labelled fibronectin fragment (FN7–10) and fixed, or fixed directly and stained with a (total) anti-ITGA5 antibody (clone PB1). Samples
were then analysed by FACS. The integrin activity index was calculated using the fibronectin and the ITGA5 signals as described in the Methods. Results are displayed as bar
charts where the individual experiments are highlighted as dots, and error bars represent standard error of the mean (** p-value = 0.0062, n = 7 of biological repeats). The
p-value was determined using a one-sample t-test. C) U2-OS or MDA-MB-231 cells transiently expressing various EGFP constructs (as indicated), were fixed and stained for
active (clone 9EG7) or total β1 integrin (clone P5D2). Staining intensity was recorded by flow cytometry and integrin activation was assessed as a ratio between active and
total integrin (9EG7/P5D2 ratio). Error bars indicate standard error of the mean (* p-value < 0.05; C, n = 5 biological repeats; D, n = 4 biological repeats). The p-values were
determined using a Student’s two-tailed t-test. D) MDA-MB-231 cells, previously silenced for MYO10 (using an siRNA targeting the 3’ UTR of MYO10 mRNA) and expressing
EGFP or EGFP-MYO10, were fixed and stained for active (clone 9EG7) or total β1 integrin (clone P5D2). Staining intensity was recorded by flow cytometry and integrin
activation was assessed as a ratio between active and total integrin (9EG7/P5D2 ratio). Error bars indicate standard error of the mean (* p-value < 0.05; n = 4 biological
repeats). The p-value was determined using a Student’s two-tailed t-test. E-F) CHO or U2-OS cells transiently expressing EGFP or EGFP-MYO10FERM were left to adhere
on fibronectin and their spreading was monitored over time using the xCELLigence system. The cell index over time is displayed, grey areas indicate the 95% confidence
intervals. The cell index at 60 min is also displayed as a bar chart (error bars indicate the standard error of the mean, *** p-value < 0.001, n = 4 biological repeats (CHO), n =
3 (U2-OS)). The p-value in bar charts was determined using a Student’s two-tailed t-test. G) U2-OS cells transiently expressing EGFP or EGFP-MYO10FERM were seeded on
fibronectin and allowed to spread for 40 min prior to fixation. Samples were imaged using a confocal microscope and the cell area measured using Fiji ( *** p-value < 0.001;
EGFP, 208 cells; EGFP-MYO10FERM, 188 cells; n = 3 biological repeats). The p-values were determined using a randomization test. Scale bars are 16 µm.
tail) (Fig. 4E). Together, these experiments demonstrate that
MYO10 binds to integrin β-tails, in line with previous reports
(Zhang et al., 2004; Hirano et al., 2011), and reveal a previ-
ously unknown interaction between MYO10-FERM and the
GFFKR motif in integrin α tails.
To test the relevance of the MYO10–α-integrin tail in-
teraction in filopodia induction, we expressed full-length
ITGA2WT and ITGA2GAAKR in CHO cells (lack endoge-
nous collagen-binding integrins) and investigated MYO10
filopodia formation on collagen I (Fig. 4F). Importantly,
ITGA2GAAKR localises to the plasma membrane and is ex-
pressed at similar levels to wild-type in CHO cells (Alanko
et al., 2015). Interestingly, the number of filopodia was sig-
nificantly lower in cells expressing the mutant integrin, in-
dicating that the GFFKR motif in the ITGA2 tail strongly
contributes to filopodia formation.
A key step in integrin activation is talin-mediated sepa-
ration of the α/β tails (Sun et al., 2019; Askari et al., 2009).
The ability of MYO10 to bind to both α and β integrin tails,
led us to hypothesize that MYO10 could inactivate integrins
by promoting an inter-αβ-clasp where both integrin tails are
forced together in close proximity (Liu et al., 2015). To as-
sess integrin tail crosslinking, we generated β1 and α2 in-
tegrin cytoplasmic tail constructs tagged with an N-terminal
membrane targeting sequence (CAAX) and a C-terminal flu-
orescent protein (mTurquoise2 or YPet). These constructs
were expressed in cells and Förster resonance energy trans-
fer (FRET) between mTurquoise2 or YPet was estimated in
cells using flow cytometry (Fig. 4G). We found that the
expression of mCherry-MYO10-FERM appeared to increase
FRET between the two constructs compared to cells express-
ing mCherry alone (Fig. 4H) and that this increase in FRET
was dependent on an intact GFFKR motif in the α2-integrin
tail (Fig. 4I). Together these data suggest that the MYO10-
FERM domain may be able to inactivate integrins through
cross-linking of the two integrin tails. However, the mecha-
nistic details remain to be fully elucidated.
MYO10-FERM domain fine-tunes integrin activity at filopo-
dia tips. To further investigate the contribution of MYO10-
FERM in regulating integrin activity in filopodia, we created
a chimaera construct, where the FERM domain from MYO10
was replaced by the one from TLN1 (MYO10TF) (Fig. 5A).
Cells expressing MYO10TF generated filopodia to nearly the
same extent as cells expressing MYO10WT (Fig. 5B). In ad-
dition, in a small proportion of cells (below 1%), MYO10TF
also localised to enlarged structures connected to stress fibres
and reminiscent of focal adhesions (Fig. 5C). The length
and the dynamics of MYO10TF filopodia were comparable
to filopodia generated by MYO10WT (Fig. 5D-F) and active
β1 integrin accumulated at the tips of MYO10TF filopodia
(Fig. 5G and 5H). These results indicate that the talin-FERM
domain can almost fully rescue the deletion of the MYO10-
FERM domain and that the chimeric MYO10TF is functional
in filopodia induction in cells. However, MYO10TF filopodia
were more likely to have active β1 integrin positive tips, indi-
cating that the talin-FERM domain may facilitate β1 integrin
activation in filopodia compared to the MYO10WT filopodia
(Fig. 5I). Interestingly, silencing of TLN1 and TLN2 still
impeded MYO10TF filopodia formation indicating that talin-
FERM fused to the MYO10 motor is not sufficient to sub-
stitute for the lack of endogenous full-length talin (Fig. S3C
and D).
Altogether, our data indicate that an integrin-binding
FERM domain coupled to a Myosin motor is required to
activate integrin at filopodia tips (Fig. 2 and 5). We also
found that the nature of this FERM domain, whether it is ca-
pable of activating or inactivating integrin, then contributes
to fine-tuning integrin activation at filopodia tips (Fig. 5).
Interestingly, other FERM domain containing myosins, in-
cluding MYO7 and MYO15, also localise to filopodia tips
(Jacquemet et al., 2019) where their roles are mostly un-
known. Future work will examine the contribution of these
unconventional myosins to filopodia functions. In particular,
we identify here that MYO10-FERM domain inhibits integrin
activation, possibly through cross-linking integrin α- and β-
cytoplasmic tails together (Fig. 3 and 4) in a similar fashion
to the integrin inactivator protein FLNA (Liu et al., 2015).
However, the exact mechanism by which MYO10-FERM in-
activates integrins, as well as the biological significance of
this finding, remains to be fully elucidated.
Our data indicate that both MYO10 and talin are re-
quired to activate integrins in a spatially controlled manner at
filopodia tips. Interestingly, live-cell imaging revealed that,
in filopodia, talin and MYO10 always co-localise (Jacquemet
et al., 2019). As the small GTPase Rap1 localises to filopo-
dia and is required to support filopodia functions (Jacquemet
et al., 2016; Lagarrigue et al., 2015), a plausible mechanism
would be that, upon filopodia initiation, talin is kept in an
auto-inhibited conformation in filopodia tips. Once activated
by Rap1 (directly or indirectly), talin auto-inhibition is re-
leased, and talin associates with and activates integrins, trig-
gering adhesion. Why MYO10-FERM domain is required
to activate integrin remains unknown. However, we spec-
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Fig. 4. MYO10 binds to both α and β integrin tails. A) Recombinant 6xHis-tagged FERM domains from TLN1 (TLN1FERM) and MYO10 (MYO10FERM) and a 6xHis peptide
(CTRL) were labelled and their binding to integrin tails was recorded using microscale thermophoresis. In these experiments, 20 nM of labelled FERM was used while the
integrin tail peptides were used at increasing concentration. Graphs were generated by pooling together 3 independent experiments (see Methods for details). B) Table
showing the Kd values obtained when measuring the binding, using microscale thermophoresis, of TLN1FERM and MYO10FERM to the indicated integrin tail peptides. For each
condition, data from 3 independent experiments were pooled together to obtain Kd values. C) Recombinant MYO10-FERM domain (MYO10FERM) was labelled and its binding
to the intracellular tails of wild type ITGA2 (ITGA2WT) or of ITGA2 mutated on the GFFKR consensus site (ITGA2GAAKR) was recorded using microscale thermophoresis. In
these experiments, 20 nM of MYO10-FERM was used while the integrin tail peptides were used at increasing concentration. Graphs were generated by pooling together 3
independent experiments (see methods for details). D) Integrin tail pull-downs were performed from U2-OS cell lysates using magnetic beads. The recruitment of MYO10
and AP2µ was then analysed by western blot (n = 3 biological experiments). A representative western blot is displayed. E) Integrin tail pull-downs were performed from
cell lysate generated from U2-OS cells stably expressing EGFP-MYO10FERM. The recruitment of endogenous MYO10, EGFP-MYO10FERM and AP2µ was then analysed by
western blot (n = 3 biological experiments). A representative western blot is displayed. F) CHO cells transiently expressing mScarlet-MYO10 and full length GFP-ITGA2WT or
GFP-ITGA2GAAKR were plated on collagen I for 2 h, fixed and imaged using a spinning-disk confocal microscope. Representative MIPs are displayed. Scale bar: 25 µm. The
number of MYO10-positive filopodia per cell was then quantified (n > 107 cells, four biological repeats; *** p-value < 0.001). P-values were determined using a randomization
test. G) Cartoons illustrating the two constructs used to measure α and β integrin tail cross-linking in cells using FRET.
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Fig. 4. (Continued from previous page.) H) U2-OS cells transiently expressing the CAAX-ITGB1 and CAAX-ITGA2WT probes, as well as mCherry or mCherry-MYO10FERM,
were analysed by flow cytometry. FRET between the CAAX-ITGB1 and CAAX-ITGA2WT probes were estimated as detailed in the Methods. Results are displayed as bar
charts where the individual experiments are visible as dots (error bars indicate the standard error of the mean, *** p-value = 3.2*10-5, n = 5 biological repeats). P-values
were determined using two-tailed Student’s t-test. I) U2-OS cells transiently expressing the CAAX-ITGB1 and mCherry-MYO10FERM constructs as well as CAAX-ITGA2WT or
CAAX-ITGA2GAAKR probes were analysed by flow cytometry. FRET between the CAAX-ITGB1 and CAAX-ITGA2 probes was estimated as detailed in the methods. Results
are displayed as bar charts where the individual experiments are visible as dots (error bars indicate the standard error of mean, *** p = 0.00025, n = 3 biological repeats).
The p-values were determined using the two-tailed Student’s t-test.
ulate that, owing to its motor domain, MYO10 allows in-
tegrins to resist the strong actin retrograde flow, present in
filopodia (Bornschlögl et al., 2013), long enough for the auto-
inhibition of talin to be released, and for the integrin to be
handed over to, and activated by talin. In this model, MYO10
could act as a sink and interact with integrins only at filopodia
tips (He et al., 2017).
The precise mechanism(s) regulating the handing over
of integrin from MYO10 to talin remains to be elucidated,
but one possibility is that talin-FERM outcompetes MYO10-
FERM. Indeed, our in vitro experiments indicate that talin-
FERM has, in solution, a higher affinity for integrin β-tail
compared to MYO10-FERM (Fig. 4). In addition, talin affin-
ity for β integrin tails will be even stronger in cells due to the
presence of negatively charged membrane phosphoinositides
(Chinthalapudi et al., 2018; Franceschi et al., 2019), which
are known to accumulate at filopodia tips (Jacquemet et al.,
2019). Collectively, these findings suggest that a motor-
coupled integrin-binding FERM domain is a core require-
ment for integrin activation in filopodia tips. Interestingly,
even though the FERM domains of talin and MYO10 have in-
terchangeable functionality in filopodia, MYO10-FERM do-
main specifically fine-tunes integrin activation in filopodia.
Material and methods.
Cells. U2-OS (human osteosarcoma cells) and MDA-MB-
231 (triple-negative human breast adenocarcinoma) cells
were grown in DMEM (Dulbecco’s Modified Eagle’s
Medium with HEPES modification; Sigma, D1152) sup-
plemented with 10% fetal bovine serum (FCS) (Biowest,
S1860). U2-OS cells were purchased from DSMZ (Leib-
niz Institute DSMZ-German Collection of Microorganisms
and Cell Cultures, Braunschweig DE, ACC 785). CHO
cells were cultured in alpha-MEM, supplemented with 5%
FCS and L-glutamine. U2-OS, MDA-MB-231 and CHO
cells were transfected using Lipofectamine 3000 and the
P3000TM Enhancer Reagent (Thermo Fisher Scientific) ac-
cording to the manufacturer’s instructions. The U2-OS
MYO10-GFP lines were generated by transfecting U2-OS
cells using lipofectamine 3000 (ThermoFisher Scientific), se-
lected using Geneticin (ThermoFisher Scientific; 400 µg.ml-1
final concentration) and sorted for green fluorescence using a
fluorescence-assisted cell sorter (FACS). All cell lines tested
negative for mycoplasma.
Plasmids. EGFP-MYO10 was a gift from Emanuel Strehler
(Addgene plasmid 47608) (Bennett et al., 2007). CRK-GFP
was a gift from Ken Yamada (Addgene plasmid 50730).
DIAPH3-GFP and VASP-GFP were gifts from Michael
Davidson (Addgene plasmids 54158 and 54297, respec-
tively). BCAR1-GFP was a gift from Daniel Rösel (Charles
University in Prague, Czech Republic) (Braniš et al., 2017).
FERMT2-GFP was a gift from Maddy Parsons (King’s Col-
lege London, UK). The following constructs were described
previously: GFP-ITGA2 and GFP-ITGA2GAAKR (Pellinen
et al., 2006), mScarlet-MYO10 (Jacquemet et al., 2019),
GFP-TLN1 (Kopp et al., 2010), GFP-TLN1FERM and His-
TLN1FERM (Goult et al., 2010).
The construct encoding the EGFP-tagged MYO10-
FERM domain (EGFP-MYO10FERM) was designed using the
boundaries from the MYO10-FERM crystal structure (Wei et
al., 2011). The MYO10 coding region 1480-2053 was ampli-
fied by PCR (primers: 5’-ATT AGA GAA TTC AAC CCG
GTG GTC CAG TGC-3’, 5’-ATT AGA GGT ACC TCA
CCT GGA GCT GCC CTG-3’) and the resulting PCR prod-
ucts were ligated into pEGFP-C1 using the EcoRI and KpnI
restriction sites.
To generate the His-tagged MYO10FERM plasmid, the
MYO10-FERM domain (boundaries 1504-2058 in MYO10)
was amplified by PCR (primers: 5’-ATT AGA GCG GCC
GCA CCG ATC GAC ACC CCC AC, 5’-ATT AG AGA
ATT CTC ACC TGG AGC TGC CCT G) and introduced in
pET151 using the NotI and EcoRI restriction sites.
The MYO10 MyTH/FERM deletion construct (EGFP-
MYO10ΔF) was generated by introducing a premature stop
codon in full length EGFP-MYO10 (boundaries 1-1512 in
MYO10) using a gene block (IDT). The gene block was in-
serted in EGFP-MYO10 using the PvuI and XbaI restriction
sites.
The mScarlet-I-MYO10ΔF construct was created from
EGFP-MYO10ΔF by swapping the fluorescent tag. The
mScarlet-I (Bindels et al., 2017) coding sequence, acquired
as a gene block (IDT), was inserted in EGFP-MYO10ΔF us-
ing the NheI and KpnI restriction sites.
The MYO10/TLN1 chimaera construct (EGFP-
MYO10TF) was generated by swapping the MYO10-FERM
domain (boundaries 1504-2056 in MYO10) with the TLN1
FERM domain (boundaries 1-398 in TLN1) using a gene
block (IDT). The gene block was inserted in EGFP-MYO10
using the PvuI and XbaI restriction sites.
The CAAX-ITGB1, CAAX-ITGA2 and CAAX-
ITGA2GAAKR constructs were generated by using the Gate-
way cloning system. Gene blocks containing the CAAX
sequence, the integrin cytoplasmic tail and mTurquoise2
or YPet were inserted into the Gateway entry backbone
pENTR2b using the XhoI/KpnI restriction sites. The open
reading frame was then transferred into the Gateway expres-
sion vector pEF.DEST51 using a standard LR reaction (Ther-
moFisher Scientific, 11791020). All the constructs generated
in this study are in the process to be deposited to Addgene.
Antibodies and other reagents. Monoclonal antibodies
recognising the extended conformation of β1 integrin (high
affinity for ligand, termed ‘active’) were mouse anti-human
β1 integrin 12G10 (generated in house from a hybridoma),
mouse anti-human β1 integrin HUTS21 (556048, BD Bio-
sciences) and rat anti-human β1 integrin 9EG7 (BD Bio-
sciences, 553715). Monoclonal antibodies recognising the
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closed conformation of β1 integrin (low affinity for ligand,
termed ‘inactive’) were mouse anti-human β1 integrin 4B4
(Beckman Coulter, 6603113) and rat anti-human β1 inte-
grin mAb13 (generated in house from a hybridoma). The
monoclonal antibody recognising all β1 integrin species was
mouse anti-human β1 integrin P5D2 (Developmental stud-
ies hybridoma bank). Other mouse monoclonal antibodies
used in this study were raised against hamster α5 integrin
(clone PB1, Developmental studies hybridoma bank), TLN1
(clone 97H6, Novus Biologicals NBP2-50320), TLN2 (clone
68E7, Novus Biologicals NBP2-50322), β-actin (Clone AC-
15, Sigma, Cat. No. A1978) and PAX (Clone 349, BD
Biosciences, 610051). The rabbit monoclonal antibody used
was raised against AP2γ (Novus Biological, EP2695Y). Rab-
bit polyclonal antibodies used were raised against GFP (Ab-
cam Ab290), MYO10 (Novus Biologicals, 22430002; 1:1000
for WB) and kindlin-1 (recognise kindlin 1 and 2, Abcam,
ab68041). Small molecule inhibitors used were RO-3306
(CDK1 inhibitor, Sigma SML0569) and blebbistatin (Stem-
cell technologies 72402). The bovine plasma fibronectin was
purchased from Merck (341631) and collagen I was pur-
chased from Sigma (C8919-20ML).
siRNA-mediated gene silencing. The expression of pro-
teins of interest was suppressed using 83 nM siRNA and
lipofectamine 3000 (Thermo Fisher Scientific) according
to manufacturer’s instructions. All siRNAs used were
purchased from Qiagen. The siRNA used as control
(siCTRL) was Allstars negative control siRNA (Qiagen,
Cat No./ID: 1027280). siRNAs targeting ACTN1 were
siACTN1 #5 (Hs_ACTN1_5, SI00299131) and siACTN1
#2 (Hs_ACTN1_2, SI00021917). siRNAs targeting TNS3
were siTNS3 #1 (Hs_TENS1_1, SI00134372) and siTNS3
#2 (Hs_TNS3_2, SI02778643). siRNAs targeting TNS1
were siTNS1 #3 (Hs_TNS_3, SI00134106) and siTNS1 #4
(Hs_TNS_4, SI00134113). siRNAs targeting FERMT1 were
siFERMT1 #5 (Hs_C20orf42_5, SI04269181), siFERMT1
#7 (Hs_C20orf42_7, SI04307219) and siFERMT1 #8
(Hs_C20orf42_8, SI04352978). siRNAs targeting FERMT2
were siFERMT2 #1 (Hs_FERMT2_1, SI04952542) and
siFERMT2 #3 (Hs_FERMT2_3, SI04952556). siRNAs
targeting CIB1 were siCIB1 #5 (Hs_CIB1_5, SI02657102)
and siCIB #7 (Hs_CIB1_7, SI03164476). siRNAs target-
ing SHARPIN were siSHARPIN #2 (Hs_SHARPIN_2,
SI00140182) and siSHARPIN #5 (Hs_SHARPIN_5,
SI03067344). siRNA targeting ITGB1BP1 were si-
ITGB1BP1 #5 (Hs_ITGB1BP1_5, SI03129385) and
siITGB1BP1 #8 (Hs_ITGB1BP1_8, SI04332832). siRNA
targeting TLN1 were siTLN1 #2 (Hs_TLN1_2, SI00086968)
and siTLN1 #3 (Hs_TLN1_3, SI00086975). siRNA tar-
geting TLN2 was siTLN2 #3 (Hs_TLN2_3, SI00109277).
siRNA targeting MYO10 were siMYO10 #5 (Hs_MYO10_5,
SI04158245), siMYO10 #6 (Hs_MYO10_6, SI04252822)
and siMYO10 #7 (Hs_MYO10_7, SI05085507).
SDS–PAGE and quantitative western blotting. Purified pro-
teins or protein extracts were separated under denaturing con-
ditions by SDS–PAGE and transferred to nitrocellulose mem-
brane using Trans-Blot Turbo nitrocellulose transfer pack
(Bio-Rad, 1704159). Membranes were blocked for 45 min
at room temperature using 1x StartingBlock buffer (Thermo
Fisher Scientific, 37578). After blocking membranes were
incubated overnight with the appropriate primary antibody
(1:1000 in PBS), washed three times in TBST and probed
for 40 min using a fluorophore-conjugated secondary anti-
body diluted 1:5000 in the blocking buffer. Membranes were
washed three times using TBST, over 15 min, and scanned
using an Odyssey infrared imaging system (LI-COR Bio-
sciences).
siRNA screen. 96-well glass-bottom plates (Cellvis, P96-
1.5H-N) were first coated with a solution of poly-D-
lysine (10 µg/ml in PBS, Sigma-Aldrich, A-003-M) at 4°C
overnight. Plates were then washed with PBS and coated
with a solution containing 10 µg/ml of bovine fibronectin
(in PBS) also at 4°C overnight. Excess fibronectin was
washed away with PBS. U2-OS cells stably expressing
MYO10-GFP were silenced for the gene of interest using a
panel of siRNAs (Qiagen flexiplate, 1704159) using Lipo-
fectamine 3000 (Thermo Fisher Scientific, L3000075). 48
h post silencing, cells were trypsinized and plated on both
fibronectin-coated 96-well glass-bottom plates and 96-well
plastic-bottom plates in full culture medium. Cells plated
in the plastic-bottom plates were allowed to spread for two
hours before being lysed using an RNA extraction buffer.
RNAs were then purified and the silencing efficiency of each
siRNA was validated by qPCR analysis. Cells plated in the
glass-bottom plates were allowed to spread for two hours
and fixed with a warm solution of 4% paraformaldehyde
(PFA, Thermo Scientific, 28906). After washing, the sam-
ples were incubated with a solution of 1 M Glycine (30 min,
in PBS) and then for one hour in a solution containing phal-
loidin–Atto647N (1/400 in PBS, Thermo Fisher Scientific,
65906) and DAPI (0.5 µg/ml in PBS, Thermo Fisher Sci-
entific, D1306). The 96-well glass-bottom plates were then
imaged using a spinning-disk confocal microscope equipped
with a 40x objective. Images were analysed using Fiji (Schin-
delin et al., 2012). Briefly, images were opened and, af-
ter background subtraction and normalization, MYO10 spots
were automatically detected using Michael Schmid’s ‘Find
maxima’ plugin. As inactive MYO10 is known to accumu-
late in rab7 vesicles (Plantard et al., 2010), to obtain an accu-
rate number of filopodia-specific MYO10 spots, intracellular
MYO10 spots were excluded from the analysis. Intracellu-
lar MYO10 spots were automatically filtered by masking the
cells using the F-actin staining. The remaining spots per field
of view were counted.
RNA extraction, cDNA preparation and Taq-Man qPCR.
Total RNA extracted using the NucleoSpin RNA Kit
(Macherey-Nagel, 740955.240C) was reverse transcribed
into cDNA using the high-capacity cDNA reverse transcrip-
tion kit (Applied Biosystems, Thermo Fisher Scientific, 43-
688-14) according to the manufacturer’s instructions. The
TaqMan primer sequences and associated universal probes
were generated using ProbeFinder (version 2.53, Roche).
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Fig. 5. MYO10-FERM domain fine-tunes integrin activity at filopodia tips. A) Cartoon illustrating the EGFP-MYO10WT and EGFP-MYO10TF constructs. B-E) U2-OS cells
transiently expressing EGFP-MYO10WT or EGFP-MYO10TF were plated on fibronectin for 2 h, fixed and imaged using a spinning-disk confocal microscope or an Airyscan
confocal microscope. B) Representative MIPs acquired on a spinning-disk confocal are displayed. Scale bar: 25 µm. C) An image acquired on an Airyscan confocal
microscope is displayed. The yellow square highlights an ROI, which is magnified. scale bars: (main) 25 µm; (inset) 5 µm. D) The number of MYO10-positive filopodia per cell
was quantified (EGP-MYO10WT, n = 33 cells; EGFP-MYO10∆F, n = 53 cells; EGFP-MYO10TF, n = 53 cells; three biological repeats; *** p-value < 0.001, * p-value = 0.043).
E) Quantification of filopodia length in U2-OS cells transiently expressing EGFP-MYO10WT, EGFP-MYO10∆F or EGFP-MYO10TF quantified from SIM images. Results of
EGFP-MYO10∆F were already displayed in figure 2 and are provided here again as reference (EGFP-MYO10WT, n = 512 filopodia; EGFP-MYO10∆F, n = 283 filopodia; EGFP-
MYO10TF n = 669 filopodia ; three biological repeats; *** p-value = <0.001). F) U2-OS cells expressing EGFP-MYO10WT or EGFP-MYO10TF were plated on fibronectin and
imaged live using an Airyscan confocal microscope (1 picture every 5 s over 20 min). For each condition, MYO10-positive particles were automatically tracked, and MYO10
spot lifetime (calculated as a percentage of the total number of filopodia generated per cell) was plotted and displayed as boxplots (three biological repeats, EGP-MYO10WT,
n= 33 cells; EGFP-MYO10TF, n= 53 cells). G) U2-OS cells expressing EGFP-MYO10TF were plated on fibronectin for 2 h, stained for active (clone 12G10) or inactive (clone
4B4) β1 integrin and F-actin, and imaged using SIM. Representative MIPs are displayed. The yellow squares highlight ROIs, which are magnified; yellow arrows highlight
filopodia tips; scale bars: (main) 20 µm; (inset) 2 µm. H) Heatmap highlighting the sub-filopodial localisation of active β1 integrin in cells expressing EGFP-MYO10WT or
EGFP-MYO10TF (EGFP-MYO10WT, n = 512 filopodia; EGFP-MYO10TF, n = 669 filopodia; three biological repeats). I) Bar chart highlighting the percentage of filopodia with
detectable levels of active β1 integrin in U2-OS cells expressing EGFP-MYO10WT, EGFP-MYO10∆F or EGFP-MYO10TF (EGFP-MYO10WT, n = 512 filopodia; EGFP-MYO10∆F,
n = 283 filopodia; EGFP-MYO10TF n = 669 filopodia; three biological repeats). For all panels, p-values were determined using a randomization test. NS indicates no statistical
difference between the mean values of the highlighted condition and the control.
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The primers themselves were ordered from IDT, and the Taq-
Man fast advanced master mix (Thermo Fisher Scientific,
4444557) was used to perform the qPCR reactions accord-
ing to the manufacturer’s instructions. Primers used in this
study were against TNS1 (cca gac acc cac ctg act tag; ttg gtg
cat tct cag tgg tg; probe 58), ACTN1 (gcc tca tca gct tgg gtt
at; cat gat gcg ggc aaa ttc; probe 7), FERMT1 (aga cgt cac
act gag agt atc tgg; tct gac cag tct tgg gat ata ttg; probe 25),
TNS3 (agg ctg cct gac aca gga; ;agg ggc tgt tca gca gag; probe
57), TLN1 (ccc tta cct ggg gag aca at; gag ctc acg gct ttg gtg;
probe 61), CIB1 (agt tcc agc acg tca tct cc; gct gct gtc aca gga
caa tc; probe 17), ITGB1BP (ttg aag ggc cat tag acc tg; gaa
caa aag gca act ttc cat c; probe 61), FERMT2 (taa aa cat ggc
gtt tca gca; cat ctg caa act cta cgg tgac; probe 48), SHARPIN
(ccc tgg ctg tga gat gtg ta; ggc cac tct ccc ctt gta ac; probe
83), FLNA (gtc acc ggt cgc tct cag; agg gga cgg ccc ttt aat;
probe 32) and TLN2 (ggt cat ggt tgg gca gat; gca tgc ttg tgt
tga tgg tc; probe 40). qPCR reactions were analysed with the
7900HT fast RT-PCR System (Applied Biosystems), and the
results were analysed using the RQ Manager Software (Ap-
plied Biosystems). Relative expression was calculated by the
2-ΔΔCT method. GAPDH mRNA levels were used to nor-
malise data between experiments and conditions.
Generation of the filopodia maps. U2-OS cells transiently
expressing the constructs of interests were plated on high tol-
erance glass-bottom dishes (MatTek Corporation, coverslip
#1.7) pre-coated first with Poly-L-lysine (10 µg/ml, 1 h at
37°C) and then with bovine plasma fibronectin (10 µg/ml,
2 h at 37°C). After 2 h, samples were fixed and perme-
abilised simultaneously using a solution of 4% PFA and
0.25% (vol/vol) Triton X-100 for 10 min. Cells were then
washed with PBS, quenched using a solution of 1 M glycine
for 30 min, and, when appropriate, incubated with the pri-
mary antibody for 1 h (1:100). After three washes, cells
were incubated with a secondary antibody for 1 h (1:100).
Samples were then washed three times and incubated with
SiR-actin (100 nM in PBS; Cytoskeleton; catalogue number:
CY-SC001) at 4°C until imaging (minimum length of stain-
ing, overnight at 4°C; maximum length, one week). Just be-
fore imaging, samples were washed three times in PBS and
mounted in vectashield (Vector Laboratories).
To map the localisation of each protein within filopo-
dia, images were first processed in Fiji (Schindelin et al.,
2012) and data analysed using R as previously described
(Jacquemet et al., 2019). Briefly, in Fiji, the brightness and
contrast of each image was automatically adjusted using, as
an upper maximum, the brightest cellular structure labelled in
the field of view. In Fiji, line intensity profiles (1-pixel width)
were manually drawn from filopodium tip to base (defined by
the intersection of the filopodium and the lamellipodium). To
avoid any bias in the analysis, the intensity profile lines were
drawn from a merged image. All visible filopodia in each im-
age were analysed and exported for further analysis (export
was performed using the “Multi Plot” function). For each
staining, line intensity profiles were then compiled and anal-
ysed in R. To homogenise filopodia length; each line inten-
sity profile was binned into 40 bins (using the median value
of pixels in each bin and the R function “tapply”). Using
the line intensity profiles, the percentage of filopodia positive
for active β1 at their tip was quantified. A positive identi-
fication was defined as requiring at least an average value
of 5000 (values between 0-65535) within the bins defining
the filopodium tip (identified using MYO10 staining). The
map of each protein of interest was created by averaging hun-
dreds of binned intensity profiles. The length of each filopo-
dia analysed were directly extracted from the line intensity
profiles.
Quantification of filopodia numbers and dynamics. For the
filopodia formation assays, cells were plated on fibronectin-
coated glass-bottom dishes (MatTek Corporation) for 2 h.
Samples were fixed for 10 min using a solution of 4%
(wt/vol) PFA, then permeabilized using a solution of 0.25%
(vol/vol) Triton X-100 for 3 min. Cells were then washed
with PBS and quenched using a solution of 1 M glycine for
30 min. Samples were then washed three times in PBS and
stored in PBS containing SiR-actin (100 nM; Cytoskeleton;
catalogue number: CY-SC001) at 4°C until imaging. Just
before imaging, samples were washed three times in PBS.
Images were acquired using a spinning-disk confocal micro-
scope (100x objective). The number of filopodia per cell
was manually scored using Fiji (Schindelin et al., 2012). To
study filopodia stability, U2-OS cells expressing MYO10-
GFP were plated for at least 2 h on fibronectin before the
start of live imaging (pictures taken every 5 s at 37°C, on
an Airyscan microscope, using a 40x objective). All live-
cell imaging experiments were performed in normal growth
media, supplemented with 50 mM HEPES, at 37°C and in
the presence of 5% CO2. Filopodia lifetimes were then mea-
sured by identifying and tracking all MYO10 spots using the
Fiji plugin TrackMate (Tinevez et al., 2017). In TrackMate,
the LoG detector (estimated bob diameter = 0.8 mm; thresh-
old = 20; subpixel localization enabled) and the simple LAP
tracker (linking max distance = 1 mm; gap-closing max dis-
tance = 1 mm; gap-closing max frame gap = 0) were used.
Light microscopy setup. The spinning-disk confocal mi-
croscope (spinning-disk confocal) used was a Marianas
spinning-disk imaging system with a Yokogawa CSU-W1
scanning unit on an inverted Zeiss Axio Observer Z1 micro-
scope controlled by SlideBook 6 (Intelligent Imaging Inno-
vations, Inc.). Images were acquired using either an Orca
Flash 4 sCMOS camera (chip size 2048 × 2048; Hama-
matsu Photonics) or an Evolve 512 EMCCD camera (chip
size 512 × 512; Photometrics). Objectives used were a 40x
water (NA 1.1, LD C-Apochromat, Zeiss), a 63× oil (NA
1.4, Plan-Apochromat, M27 with DIC III Prism, Zeiss) and a
100x oil (NA 1.4 oil, Plan-Apochromat, M27) objective. The
structured illumination microscope (SIM) used was DeltaVi-
sion OMX v4 (GE Healthcare Life Sciences) fitted with a
60x Plan-Apochromat objective lens, 1.42 NA (immersion
oil RI of 1.516) used in SIM illumination mode (five phases
x three rotations). Emitted light was collected on a front-
illuminated pco.edge sCMOS (pixel size 6.5 mm, readout
speed 95 MHz; PCO AG) controlled by SoftWorx. The con-
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focal microscope used was a laser scanning confocal micro-
scope LSM880 (Zeiss) equipped with an Airyscan detector
(Carl Zeiss) and a 40x oil (NA 1.4) objective. The micro-
scope was controlled using Zen Black (2.3), and the Airyscan
was used in standard super-resolution mode.
Integrin activity assays. CHO cells detached using Hyclone
HyQTase (Thermo Fisher Scientific, SV300.30.01) were pre-
treated for 10 min with 5 mM EDTA, or with PBS and
then incubated for 40 min with Alexa Fluor 647 labelled fi-
bronectin fragment (FN 7-10). After washing away the un-
bound fibronectin (using Tyrode’s buffer: 10 mM HEPES-
NaOH, pH 7.5, 137 mM NaCl, 2.68 mM KCl, 0.42 mM
NaH2PO4, 1.7 mM MgCl2, 11.9 mM NaHCO3, 5 mM glu-
cose, and 0.1% BSA), cells were fixed with 4% of PFA (in
PBS) for 10 min at room temperature. Part of the HyQ-
Tase treated cells were also fixed with 4% PFA (in PBS)
and stained with an anti-α5 integrin antibody (2 h at 4°C,
1:10 in PBS, clone PB1, Developmental studies hybridoma
bank) and with an Alexa Fluor 647-conjugated secondary an-
tibody (45 min at RT, 1:200 in PBS, Thermo Fisher Scien-
tific, A-21235). Fluorescence intensity was recorded using
FACS (BD LSRFortessa™). Data were gated and analyzed
using the Flowing Software. The integrin activity index (AI)
was calculated as indicated bellow, where F = FN7-10 signal,
FEDTA = FN7-10 signal in EDTA treated cells and FPB1 = α5
integrin signal.
AI = (F −FEDTA)
FPB1
(1)
MDA-MB-231 and U2-OS cells detached using Hy-
clone HyQTase (Thermo Fisher Scientific, SV300.30.01)
were fixed with 4% PFA (in PBS) for 10 min and stained
for active (clone 9EG7) and total β1 integrin (clone P5D2)
overnight at 4°C. Cells were then stained with the appropri-
ate Alexa Fluor 647-conjugated secondary antibody (45 min
at RT, 1:200, Thermo Fisher Scientific) and the fluorescence
was recorded using FACS. Data were gated and analyzed us-
ing the Flowing Software, and the integrin activity (IA) was
calculated as indicated below where F9EG7 and FP5D2 are the
signals intensities of the 9EG7 and P5D2 stainings, respec-
tively. F2nd Ab corresponds to the signal intensity recorded
when the cells are stained with only the secondary antibody.
IA= F9EG7−F2ndAb
FP5D2−F2ndAb (2)
FACS FRET. FACS data acquisition was performed with
LSRFortessa™ flow cytometer (BD Biosciences) controlled
by the BD FACSDiva™ software. To excite and detect
mTurquoise2 and YPet fluorophores, a 504 nm laser line
together with a filter set composed of a 475 long-pass fil-
ter and a narrow 540/30 nm filter was used. To detect
the mCherry fluorophore, a 561 nm laser line was used to-
gether with a filter set composed of a 600 nm long-pass fil-
ter and a narrow 610/20 nm filter. FRET was estimated in
mTurquoise2/YPet/mCherry triple-positive cells by measur-
ing the fluorescent signal intensity recorded in the 540/30 nm
channel (FRET channel) following 504 nm excitation. The
FRET channel intensity (Fig 4H and 4I) was calculated, for
each condition, as the average of the signal intensity mea-
sured in the FRET channel (10 000 cells per condition) nor-
malised to the sum of the mean of each condition. Results are
plotted as bar charts where each biological repeat is displayed
as a data point. Raw data were analysed using the Flowing
Software v. 2.5. FPbase spectra viewer was used to aid in the
selection of the laser-lines and filter sets before starting the
experiments (Lambert, 2019).
Cell spreading assay. The xCELLigence RTCA instrument
(Roche) was used to measure cell adhesion on fibronectin in
real-time (Hamidi et al., 2017). The RTCA instrument uses
gold-bottom electrode plates to measure the impedance be-
tween two electrodes. This is expressed as an arbitrary cell
index value. The xCELLigence 96-well plates (Acea Bio-
sciences, E-Plate VIEW 96 PET, 00300600900) were coated
with a solution of 20 µg/ml of poly-D-lysine (in PBS) for 1 h
at 37°C, washed with PBS, and coated with a solution of 10
µg/ml fibronectin (in PBS) for 1 h at 37°C. Plates were then
blocked using a solution of 1% BSA (in PBS) for 1 h in RT.
After 2 PBS washes, 15000 cells were seeded into each well
in serum-free culture medium. The cell index was recorded
over time.
Recombinant protein expression and purification. The E.
coli BL-21(DE3) strain was transformed with IPTG in-
ducible, His-tagged expression constructs, and the trans-
formed bacteria were grown at 37°C in LB media supple-
mented with ampicillin (1 mg/ml) until OD600 was 0.6-0.8.
Protein expression was then induced using IPTG (0.5 mM),
and the temperature was lowered to 25°C. Cells were har-
vested after 5 h by centrifugation (20 min at 6000 g). Bac-
teria were then resuspended in a resuspension buffer (1x
TBS, cOmplete™ protease inhibitor tablet (Roche, cat. no.
5056489001), 1x AEBSF inhibitor, 1x PMSF, RNase 0.05
mg/ml, DNase 0.05 mg/ml). To lyse the bacteria, a small
spoonful of lysozyme and 1x BugBuster (Merck Millipore,
cat. no. 70584-4) were added, and the suspension was ag-
itated for 30 min at 4°C. Cell debris was pelleted using a
JA25.5 rotor at 20000 rpm for 1 h. His-tagged proteins were
batch purified from the supernatant using a Protino Ni-TED
2000 column (Macherey Nagel, cat. no. 745120.25) ac-
cording to manufacturer’s instructions. Proteins were eluted
using the elution buffer provided with the kit supplemented
with 1 mM AEBSF. For each purified protein, several 1 ml
fractions were collected, ran on a 4-20% protein gel (Bio-
Rad Mini-PROTEAN TGX, #4561093), stained with Instant-
Blue® (Expedeon, ISB1L) and the fractions abundant in
tagged protein were combined. Imidazole was removed in
a buffer exchange overnight at 4°C and 1 mM AEBSF was
added to the imidazole-free protein. Proteins were stored at
4°C for up to one week.
Whole-mount immuno-SEM. U2-OS cells expressing
MYO10-GFP were plated for 2 h on fibronectin-coated
coverslips and fixed with a solution of 4% PFA (in 0.1 M
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HEPES, pH 7.3) for 30 min. After washing and quenching
with 50 mM NH4Cl (in 0.1 M HEPES), non-specific binding
was blocked with a buffer containing 2% BSA (in 0.1 M
HEPES). Samples were then labelled using the appropriate
primary antibody (1:10 in 0.1 M HEPES) for 30 min,
washed, and labelled with a gold conjugated secondary
antibody (1:50 in 0.1 M HEPES, 30 nm gold particles, BBI
solutions, EM.GAF30) for 30 min. After immunolabeling,
the samples were washed, and post-fixed with a solution
of 2.5% glutaraldehyde and 1% buffered osmium tetroxide
prior to dehydration and drying using hexamethyldisilazane.
The dried samples were mounted on SEM stubs and sputter-
coated with carbon. The micrographs were acquired with
FEI Quanta FEG 250 microscope with SE and vC detectors
(FEI Comp.) using an acceleration voltage of 5.00 kV and a
working distance ranging from 7.7 to 10.9 mm.
Integrin tail pull-downs. For each pulldown, 20 µl of strep-
tavidin Dynabeads (MyOne Streptavidin C1, Invitrogen,
65001) were incubated, for 30 min, on ice, with the appro-
priate biotinylated integrin tail peptides (LifeTein). U2-OS
cells were washed twice with cold PBS and lysed on ice with
a buffer containing 40 mM HEPES, 75 mM NaCl, 2 mM
EDTA, 1% NP-40, a cOmplete™ protease inhibitor tablet
(Roche, 5056489001) and a phosphatase-inhibitor tablet
(Roche, 04906837001). Samples were cleared by centrifu-
gation (13,000 g, 10 min) and incubated with the streptavidin
Dynabeads for 2 h at 4°C. Beads were washed three times
with a washing buffer (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1% (v/v) NP-40) and proteins bound to the beads were
eluted using SDS sample buffer and heated 5-10 min at 90°C.
Results were analyzed using western blot. Integrin peptides
used were wild-type β1-integrin tail (KLLMIIHDRREFAK-
FEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK), the
β1-integrin tail where the NPXY motif is deleted (KLLMI-
IHDRREFAKFEKEKMNAKWDTGEN), the conserved re-
gion of the α2-integrin tail (WKLGFFKRKYEKM), the con-
served region of α2-integrin tail peptide where the GFFKR
motif is mutated (GAAKR mutant, WKLGAAKRKYEKM)
and the wild-type α5-integrin tail (KLGFFKRSLPYG-
TAMEKAQLKPPATSDA).
Microscale thermophoresis. Recombinant His-tagged pro-
teins were labelled using the Monolith His-Tag Labeling
Kit RED-tris-NTA (NanoTemper, MO-L008). In all exper-
iments, the labelled His-tagged recombinant proteins were
used at a concentration of 20 nM while the integrin tail pep-
tides were used at increasing concentration. Kd values were
calculated using the equation provided below (Eq.1), where
Kd is the dissociation constant, [A] the concentration of the
free fluorescent molecule, [L] the concentration of the free
ligand, [AL] the concentration of the AL-complex. [A0] is
the known concentration of the fluorescent molecule and [L0]
is the known concentration of added ligand. This leads to a






Alternatively, binding was also expressed as a change
in MST signal (normalized fluorescence ΔFnorm). This is
defined as a ratio:
∆Fnorm=F1/F0 (4)
Where F0 is the fluorescence prior and F1 after IR laser
activation.
All binding data were analyzed using MO.Control and
MO.Affinity software (NanoTemper).
Quantification and statistical analysis. Randomization
tests were performed using the online tool PlotsOfDiffer-
ences (Goedhart, 2019). Dot plots were generated using
PlotsOfData (Postma and Goedhart, 2019). Bar plots with
visualized data points, time-series data and density plots
were generated using R, Rstudio (Integrated Development
for R. RStudio, Inc., Boston, MA) and ggplot2 (Wick-
ham, 2016). Other statistical analyses were performed us-
ing Google sheets except for the one-sample t-test which was
performed using an online calculator.
Data availability. The authors declare that the data support-
ing the findings of this study are available within the article
and from the authors on request.
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Fig. S1. Modulation of filopodia properties by focal adhesions and known integrin activity regulators. A-B) U2-OS cells
expressing EGFP-MYO10 were plated on fibronectin for 1 h and treated for another hour with 10 µM RO-3306 (CDK1 inhibitor) or
DMSO. Cells were stained for paxillin (PAX) and F-actin, and imaged using an Airyscan confocal microscope or a spinning disk confocal
microscope. (A) Representative Airyscan images are displayed. The yellow rectangles highlight ROIs, which are magnified; scale bars:
(main) 25 µm; (inset) 5 µm. (B) The number of MYO10-positive filopodia per cell was then quantified from the spinning disk images (n >
72 cells, two biological repeats; *** p-value = 0.003). C) Quantification of filopodia length, from SIM images, in U2-OS cells transiently
expressing EGFP-MYO10 and treated for 1 h with 10 µM RO-3306 (CDK1 inhibitor) or DMSO (DMSO, n = 734 filopodia; RO-3306, n =
824 filopodia; three biological repeats; *** p-value = <0.001).
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Fig. S1. (Continued from previous page.) D-F) RNAi screen of known integrin activity regulators. The indicated genes were silenced
individually or together in U2-OS cells stably expressing EGFP-MYO10 using two independent siRNA oligos per gene. Cells were
seeded on fibronectin-coated glass-bottom 96-well plates for 2 h and samples were fixed and stained. Samples were imaged using
a spinning disk confocal microscope and the number of filopodia per field of view (FOV) was quantified automatically using ImageJ
(see Methods for details). D) Results are displayed as dot plots. In addition, the effect size was calculated using bootstrapping to
resample the median values for each of the conditions using PlotsOfDifferences (Goedhart, 2019). * p-value < 0.05. E) The efficiency
of siRNA-mediated silencing of each target (except MYO10) was quantified by qPCR and normalised to GAPDH expression. The results
were further normalised against expression detected in siCTRL cells. F) Efficiency of siRNA-mediated (oligos #5 and #6) silencing of
MYO10 in U2-OS cells validated by western blot. G) Efficiency of dual siRNA-mediated silencing of FERMT1 and FERMT2 in U2-OS
cells validated by western blot. H) FERMT1- and FERMT2-silenced U2-OS cells transiently expressing EGFP-MYO10 were plated on
fibronectin for 2 h, fixed, and the number of MYO10-positive filopodia per cell was quantified (n > 70 cells, three biological repeats). I)
FERMT1- and FERMT2-silenced U2-OS cells transiently expressing EGFP-MYO10 were plated on fibronectin and imaged live using
an Airyscan confocal microscope (1 picture every 5 s over 20 min). For each condition, MYO10-positive particles were automatically
tracked, and MYO10 spot lifetime (calculated as a percentage of the total number of filopodia generated per cell) was plotted and
displayed as boxplots (see Methods for details; three biological repeats, more than 21 cells per condition). For all panels, p-values were
determined using a randomization test. NS indicates no statistical difference between the mean values of the highlighted condition and
the control.
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Fig. S2. MYO10 FERM deletion has minimal impact on filopodia tip protein localisation. U2-OS cells expressing MYO10WT-
mScarlet or MYO10∆F-mScarlet-I together with TLN1-GFP, FERMT2-GFP, CRK-GFP, DIAPH3-GFP, BCAR1-GFP or VASP-GFP were
plated on fibronectin for 2 h, fixed, stained for F-actin and imaged using SIM. Representative MIPs are displayed. The yellow squares
highlight ROIs, which are magnified; yellow arrows highlight filopodia tips; scale bars: (main) 20 µm; (inset) 2 µm.
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Fig. S3. Validation of MYO10 and TLN1/2 reagents. A) The efficiency of siRNA-mediated silencing of MYO10 in U2-OS cells was
validated by western blot. The siMYO10 #7 oligo targets the 3’ UTR of the MYO10 mRNA. B) Recombinant his-tagged TLN1 and
MYO10 FERM domains were produced in bacteria and subsequently purified using a gravity Ni2+ column. A representative gel stained
with Instant blue is displayed. C) Efficiency of dual siRNA-mediated silencing of TLN1 and TLN2 in U2-OS cells. A representative
western blot is displayed. D) TLN1 and TLN2-silenced U2-OS cells transiently expressing EGFP-MYO10WT or EGFP-MYO10TF were
plated on fibronectin for 2 h, fixed, stained, imaged using a spinning-disk confocal microscope, and the number of MYO10-positive
filopodia per cell was quantified (siCTRL/MYO10WT, n = 83 cells; siCTRL/MYO10TF, n = 66 cells; siTLN1 and siTLN2/MYO10WT, n =
75 cells; siTLN/MYO10TF, n = 71 cells; three biological repeats, *** p-value < 0.001).
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